Shailan B Shah, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A72870 · Current
Licensed to practise in California · since 2000 · expires 2028-02-29 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$1,595
Medicare paid this office $1,595 for 39 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $180 | $7 |
Who their Medicare patients are
39 Original Medicare patients in 2024. Average age 68 · Under 65 39% · Women 46% · Also on Medicaid 46% · Health risk score 3.19. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 51% · Coronary heart disease 51% · Heart failure 51% · Atrial fibrillation 44% · Chronic kidney disease 41%.
The office billed $8,392, Medicare allowed $2,428 and paid $1,595; for 49 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 39 | 49 | 68 | 3.19 | $8,392 | $1,595 |
| 2023 | 51 | 73 | 71 | 2.36 | $12,536 | $2,596 |
| 2022 | 45 | 66 | 70 | 1.98 | $12,077 | $2,350 |
| 2021 | 49 | 81 | 69 | 2.69 | $10,361 | $2,520 |
| 2020 | 22 | 23 | 68 | 3.59 | $4,084 | $968 |
| 2019 | 32 | 49 | 73 | 2.45 | $5,343 | $1,343 |
| 2018 | 45 | 58 | 70 | 2.81 | $5,469 | $1,205 |
| 2017 | 58 | 73 | 72 | 2.67 | $5,700 | $1,300 |
| 2016 | 38 | 50 | 71 | 2.66 | $4,126 | $993 |
| 2015 | 46 | 62 | 71 | 2.06 | $6,027 | $1,384 |
| 2014 | 53 | 77 | 71 | 2.12 | $5,480 | $1,323 |
| 2013 | 50 | 58 | 73 | 2.36 | $3,809 | $945 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 33 | $292 | $7 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $238 | $7 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 35 | $328 | $6 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $109 | $6 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $198 | $7 |
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 37 | $336 | $7 |
2017: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 46 | $399 | $7 |
2016: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 29 | $218 | $6 |
2015: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 36 | $281 | $7 |
2014: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 46 | $348 | $6 |
2013: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $340 | $7 |
Medicaid work
$2,676 in 2024
Medicaid paid $2,676 for 299 billed services this clinician did in 2024, up to 61 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 299 | $2,676 |
| 2024 | 299 | 1 | 61 | $2,676 |
| 2023 | 271 | 2 | 46 | $187 |
| 2022 | 256 | 1 | 60 | $407 |
| 2021 | 187 | 1 | 50 | $296 |
| 2020 | 57 | 1 | 21 | $132 |
| 2019 | 87 | 1 | 22 | $78 |
| 2018 | 89 | 1 | 19 | $236 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 259 | $187 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 256 | $407 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 187 | $296 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 57 | $132 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 87 | $78 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 89 | $236 |
Drugs they prescribed that Part D paid
$155,711
Pharmacies billed $155,711 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 734) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
587 generic and 147 brand-name prescriptions · $155,711 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 45 | $55,583 | $1,235 |
| Jardiance | 54 | $23,857 | $442 |
| Brilinta | 16 | $22,838 | $1,427 |
| Flecainide Acetate | 88 | $4,740 | $54 |
| Bumetanide | 14 | $2,471 | $177 |
See all 19 drugs
| Entresto | 45 | $55,583 | $1,235 |
| Jardiance | 54 | $23,857 | $442 |
| Brilinta | 16 | $22,838 | $1,427 |
| Flecainide Acetate | 88 | $4,740 | $54 |
| Bumetanide | 14 | $2,471 | $177 |
| Ranolazine Er | 23 | $2,277 | $99 |
| Sotalol | 44 | $1,532 | $35 |
| Amiodarone | 47 | $1,394 | $30 |
| Furosemide | 44 | $781 | $18 |
| Clopidogrel | 29 | $566 | $20 |
| Potassium Chloride | 17 | $495 | $29 |
| Metoprolol | 37 | $486 | $13 |
| Spironolactone | 42 | $463 | $11 |
| Torsemide | 13 | $314 | $24 |
| Carvedilol | 19 | $235 | $12 |
| Digoxin | 14 | $221 | $16 |
| Hydralazine | 15 | $217 | $14 |
| Losartan | 17 | $208 | $12 |
| Amlodipine Besylate | 12 | $160 | $13 |
Year by year
| 2024 | 734 | 227 | 0% (0) | 20% | $155,711 |
| 2023 | 685 | 215 | 0% (0) | 26% | $153,250 |
| 2022 | 667 | 207 | 0% (0) | 26% | $115,297 |
| 2021 | 568 | 178 | 0% (0) | 19% | $77,745 |
| 2020 | 418 | 136 | 0% (0) | 14% | $288,368 |
| 2019 | 427 | 137 | 0% (0) | 19% | $55,764 |
| 2018 | 453 | 140 | 0% (0) | 18% | $37,018 |
| 2017 | 464 | 133 | 0% (0) | 25% | $51,988 |
| 2016 | 457 | 157 | 0% (0) | 27% | $56,426 |
| 2015 | 513 | 168 | None | 30% | $55,025 |
| 2014 | 433 | 144 | 0% (0) | 22% | $56,403 |
| 2013 | 426 | 149 | None | None | $54,516 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Entresto | 61 | $63,701 | $1,044 |
| Jardiance | 62 | $36,890 | $595 |
| Flecainide Acetate | 86 | $4,495 | $52 |
| Amiodarone | 48 | $1,718 | $36 |
| Ranolazine Er | 14 | $1,339 | $96 |
| Sotalol | 43 | $1,166 | $27 |
| Furosemide | 46 | $718 | $16 |
| Metoprolol | 39 | $607 | $16 |
| Digoxin | 20 | $454 | $23 |
| Potassium Chloride | 12 | $427 | $36 |
| Torsemide | 17 | $368 | $22 |
| Atorvastatin | 19 | $359 | $19 |
| Spironolactone | 29 | $282 | $10 |
| Clopidogrel | 12 | $238 | $20 |
| Metoprolol | 18 | $192 | $11 |
| Losartan | 17 | $184 | $11 |
| Lisinopril | 12 | $160 | $13 |
| Rosuvastatin | 11 | $159 | $14 |
| Isosorbide Mononitrate Er | 11 | $118 | $11 |
2022: 16 drugs
| Entresto | 44 | $36,485 | $829 |
| Jardiance | 24 | $15,417 | $642 |
| Flecainide Acetate | 80 | $4,724 | $59 |
| Amiodarone | 88 | $3,138 | $36 |
| Sotalol | 38 | $1,525 | $40 |
| Potassium Chloride | 30 | $1,308 | $44 |
| Furosemide | 64 | $987 | $15 |
| Torsemide | 17 | $830 | $49 |
| Metoprolol | 39 | $754 | $19 |
| Hydralazine | 16 | $485 | $30 |
| Clopidogrel | 13 | $270 | $21 |
| Losartan | 21 | $228 | $11 |
| Atorvastatin | 14 | $228 | $16 |
| Lisinopril | 16 | $209 | $13 |
| Metoprolol | 14 | $170 | $12 |
| Spironolactone | 15 | $152 | $10 |
2021: 16 drugs
| Entresto | 23 | $15,400 | $670 |
| Pradaxa | 13 | $9,563 | $736 |
| Jardiance | 13 | $7,632 | $587 |
| Flecainide Acetate | 80 | $5,344 | $67 |
| Dofetilide | 12 | $2,458 | $205 |
| Sotalol | 41 | $1,785 | $44 |
| Amiodarone | 52 | $1,666 | $32 |
| Metoprolol | 39 | $1,043 | $27 |
| Furosemide | 39 | $689 | $18 |
| Klor-Con M20 | 11 | $626 | $57 |
| Metoprolol | 37 | $393 | $11 |
| Atorvastatin | 20 | $228 | $11 |
| Lisinopril | 17 | $211 | $12 |
| Amlodipine Besylate | 11 | $135 | $12 |
| Isosorbide Mononitrate Er | 11 | $128 | $12 |
| Amoxicillin | 13 | $75 | $6 |
2020: 11 drugs
| Vyndamax | 12 | $245,454 | $20,455 |
| Pradaxa | 14 | $9,298 | $664 |
| Flecainide Acetate | 86 | $4,670 | $54 |
| Sotalol | 27 | $1,549 | $57 |
| Metoprolol | 39 | $1,027 | $26 |
| Amiodarone | 20 | $722 | $36 |
| Metoprolol | 28 | $306 | $11 |
| Clopidogrel | 11 | $264 | $24 |
| Losartan | 18 | $240 | $13 |
| Lisinopril | 20 | $240 | $12 |
| Isosorbide Mononitrate Er | 11 | $128 | $12 |
2019: 14 drugs
| Pradaxa | 26 | $14,315 | $551 |
| Flecainide Acetate | 87 | $6,061 | $70 |
| Sotalol | 24 | $1,287 | $54 |
| Metoprolol | 27 | $1,070 | $40 |
| Propafenone | 11 | $968 | $88 |
| Amiodarone | 19 | $590 | $31 |
| Metoprolol | 31 | $385 | $12 |
| Digoxin | 12 | $374 | $31 |
| Atorvastatin | 11 | $323 | $29 |
| Furosemide | 14 | $319 | $23 |
| Clopidogrel | 13 | $315 | $24 |
| Hydralazine | 11 | $252 | $23 |
| Losartan | 18 | $233 | $13 |
| Lisinopril | 17 | $198 | $12 |
2018: 14 drugs
| Pradaxa | 22 | $11,638 | $529 |
| Flecainide Acetate | 88 | $6,495 | $74 |
| Metoprolol | 13 | $790 | $61 |
| Amiodarone | 25 | $647 | $26 |
| Metoprolol | 47 | $586 | $12 |
| Atorvastatin | 14 | $509 | $36 |
| Clopidogrel | 17 | $498 | $29 |
| Furosemide | 23 | $382 | $17 |
| Atenolol | 23 | $360 | $16 |
| Losartan | 17 | $336 | $20 |
| Lisinopril | 25 | $325 | $13 |
| Sotalol | 14 | $280 | $20 |
| Carvedilol | 15 | $208 | $14 |
| Amoxicillin | 14 | $88 | $6 |
2017: 15 drugs
| Pradaxa | 34 | $16,425 | $483 |
| Flecainide Acetate | 62 | $5,259 | $85 |
| Dilt-Xr | 22 | $1,357 | $62 |
| Propafenone | 11 | $1,035 | $94 |
| Atorvastatin | 29 | $897 | $31 |
| Amiodarone | 30 | $850 | $28 |
| Clopidogrel | 22 | $660 | $30 |
| Hydralazine | 13 | $555 | $43 |
| Carvedilol | 35 | $488 | $14 |
| Furosemide | 27 | $444 | $16 |
| Metoprolol | 31 | $358 | $12 |
| Isosorbide Mononitrate Er | 11 | $208 | $19 |
| Lisinopril | 14 | $207 | $15 |
| Atenolol | 12 | $155 | $13 |
| Amoxicillin | 12 | $78 | $6 |
2016: 11 drugs
| Pradaxa | 33 | $14,497 | $439 |
| Flecainide Acetate | 60 | $10,008 | $167 |
| Diltiazem 12hr Er | 11 | $2,369 | $215 |
| Atorvastatin | 35 | $1,164 | $33 |
| Amiodarone | 30 | $1,003 | $33 |
| Clopidogrel | 26 | $926 | $36 |
| Metoprolol | 39 | $432 | $11 |
| Carvedilol | 27 | $345 | $13 |
| Furosemide | 21 | $338 | $16 |
| Lisinopril | 22 | $303 | $14 |
| Atenolol | 18 | $209 | $12 |
2015: 12 drugs
| Pradaxa | 29 | $12,351 | $426 |
| Flecainide Acetate | 63 | $11,547 | $183 |
| Clopidogrel | 37 | $1,881 | $51 |
| Propafenone | 12 | $1,768 | $147 |
| Atorvastatin | 39 | $1,234 | $32 |
| Amiodarone | 27 | $846 | $31 |
| Isosorbide Mononitrate Er | 14 | $598 | $43 |
| Furosemide | 41 | $591 | $14 |
| Losartan | 20 | $581 | $29 |
| Metoprolol | 41 | $468 | $11 |
| Lisinopril | 33 | $438 | $13 |
| Carvedilol | 29 | $364 | $13 |
2014: 12 drugs
| Flecainide Acetate | 69 | $13,004 | $188 |
| Pradaxa | 22 | $9,835 | $447 |
| Sotalol | 13 | $2,768 | $213 |
| Propafenone | 14 | $2,316 | $165 |
| Clopidogrel | 20 | $948 | $47 |
| Atorvastatin | 25 | $727 | $29 |
| Amiodarone | 22 | $716 | $33 |
| Metoprolol | 43 | $547 | $13 |
| Furosemide | 24 | $385 | $16 |
| Carvedilol | 24 | $314 | $13 |
| Lisinopril | 20 | $219 | $11 |
| Isosorbide Mononitrate Er | 13 | $209 | $16 |
2013: 11 drugs
| Flecainide Acetate | 69 | $14,157 | $205 |
| Clopidogrel | 27 | $1,948 | $72 |
| Amiodarone | 20 | $842 | $42 |
| Atorvastatin | 12 | $434 | $36 |
| Carvedilol | 30 | $432 | $14 |
| Metoprolol | 39 | $415 | $11 |
| Isosorbide Mononitrate Er | 19 | $413 | $22 |
| Losartan | 16 | $386 | $24 |
| Furosemide | 20 | $253 | $13 |
| Atenolol | 19 | $225 | $12 |
| Lisinopril | 18 | $222 | $12 |
Professional record
- NPI
- 1366592164
- Licence
- CA A72870California A72870: Current · expires 2028-02-29
- Trained
- Columbia University College of Physicians and Surgeons, 1999
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A728700
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2007-01-12
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.